Found: 11
Select item for more details and to access through your institution.
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4835653
- By:
- Publication type:
- Article
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
- Published in:
- Journal of Inflammation Research, 2022, v. 15, p. 5721, doi. 10.2147/JIR.S385921
- By:
- Publication type:
- Article
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10630-x
- By:
- Publication type:
- Article
Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1336619
- By:
- Publication type:
- Article
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8<sup>+</sup> T cell recruitment.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02097-6
- By:
- Publication type:
- Article
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1223632
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1234342
- By:
- Publication type:
- Article
Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1210835
- By:
- Publication type:
- Article
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.
- Published in:
- Journal of Gastroenterology, 2023, v. 58, n. 4, p. 413, doi. 10.1007/s00535-023-01976-x
- By:
- Publication type:
- Article
Size‐Tunable Nanoregulator‐Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 30, p. 1, doi. 10.1002/adhm.202302013
- By:
- Publication type:
- Article
A risk‐based postresection follow‐up strategy for hepatocellular carcinoma patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 569, doi. 10.1002/cncr.34601
- By:
- Publication type:
- Article